소세포 폐암 (SCLC) 의 치료
Small-cell lung cancer (SCLC) – 13–15% of newly diagnosed lung cancer per year. – Most patients present with extensive stage disease –> expected survival : 2~4 months without Tx. Five year survival rates – Limited-stage SCLC : 10–13% – Extensive-stage SCLC : 1–2% WHO classification – 2 types of SCLC : pure … 더 읽기